Envista Q2 Revenue Jumps 7.7%
Envista (NYSE:NVST), a dental equipment and solutions company serving dental professionals in over 130 countries, announced its second quarter 2025 earnings on July 31, 2025. The standout news was that it surpassed Wall Street estimates on both revenue (GAAP) and adjusted earnings per share (non-GAAP). It also raised its full-year outlook for core sales growth and adjusted EPS for FY2025. Revenue (GAAP) totaled $682 million for Q2 2025, well above the expected $640.01 million. Adjusted EPS was $0.26 versus the consensus estimate of $0.23. Overall, the period saw strong operational improvements, broad-based growth across segments and geographies, and meaningful margin gains, even as free cash flow (non-GAAP) declined compared to the prior year for the first half of 2025.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
Envista specializes in dental equipment, implants, orthodontic solutions, and diagnostic tools. It supports dental practices, dental service organizations, and specialists with products like dental implants, Spark clear aligners, and diagnostic imaging equipment. The company’s broad offering ranges from consumable supplies to advanced digital and personalized treatments.
Source Fool.com
